Rapid Testing

Why Test?

Although the current public distancing and shelter at home orders have successfully helped to flatten the curve of those infected with COVID-19, we still need a strategy to slowly lift these measures so our society may return to work and communities may continue to socialize.  Part of this strategy must include large scale testing.

Our rapid test relies on a single finger stick blood test to rapidly determine if you have active infection or possible antibodies.

Who should be tested?

Many people that had a fever, cough and symptoms concerning for COVID 19 infection were unable to be tested early on due to the lack of testing capability.  You might wonder if that recent illness could have actually been due to  COVID 19.  Or you may have current symptoms of fever, cough, fatigue or body aches and are concerned for active infection.  If so you need to be tested.

In order to best identify those with active infection, the current test relies on your immune system which may require 3-5 days of symptoms before accurately reflecting an IgM active immune response.  However, even if your symptoms have already resolved the rapid IgG test will also assess for potential immunity as soon as 14 days from infection onset.

Get Your Screening

Get your COVID-19 Screening today

Fill out the COVID-19 Self Assessment below then schedule your screening with your local IV Bars. Developed with CDC, the White House & FEMA.

Get Tested


The COVID-19 IgG/IgM Rapid Test Cassette
(Whole Blood/Serum/Plasma)
This is a two part test



With the help from our local communities we are currently able to offer drive-through antibody testing in limited numbers on a first come first serve basis.  If your community is interested in setting up a mobile testing unit please contact us



We will come to your place of business and test your employees on site.  Please contact us for further information on setting up testing at your place of business.  A minimum of 15 tests is required for this pricing option.



Have testing performed in the privacy of your residence.  One of our trained personnel will visit you where you are located and perform your test on site.  A travel fee will be added based on your location.  Please contact us to setup your private testing session.

What is Antibody Testing?

COVID-19 IgG/IgM Rapid Test
Is a solid phase immunochromatographic assay for the rapid, qualitative and differential detection of IgG and IgM antibodies to 2019 Novel Coronavirus in human whole blood, serum or plasma. This test provides only a preliminary test result. Therefore, any reactive specimen with the COVID -19 IgG/IgM Rapid Test (Whole Blood/Serum /PLASMA) must be confirmed with clinical findings and alternative testing method(s) for example molecular testing such as Real-Time PCR. IgM antibodies appear will appear within blood as soon as 3-5 days for symptomatic patients and 7 days for asymptomatic patients. IgG antibodies appear in blood within 2 weeks after infection. Over time blood concentration of both IgM decrease, where IgM will become undetectable, but IgG will remain elevated. Results from antibody testing should not be used as the sole basis to diagnose or exclude SARS-CoV-2 infection or to inform infection status.


Find a local iV Bars near you and schedule your iV Today!

white logo of iV bars Babylon
white logo of iV bars Addison Texas
white logo of iV bars Addison Texas
white logo of iV bars Addison Texas
logo of iV bars Frisco Texas
logo of iV bars Garland Texas
logo of iV bars Indianapolis Indiana
logo of iV bars Long Island
logo of iV bars new york
logo of iV bars Memphis Tennessee
logo of iV bars new york
logo of iV bars Rockwall Texas
logo of iV bars of San Antonio Texas
logo of iV bars of Southlake Texas
logo of iV bars of Southlake Texas
logo of iV bars of Southlake Texas
logo of iV bars of Vail Colorado
logo of iV bars of Vail Colorado
logo of iV bars of Vail Colorado


Emergency Use Authorization (EUA) for distribution and/or use of the COVID-19 Rapid Antibody Test for the in vitro qualitative detection of the presence of IgM and/or IgG antibody to SARS-CoV-2 in human serum, plasma and/or whole blood specimens collected from individuals who display signs of symptoms of COVID-19, were exposed to an individual infected with COVID-19, or want qualitative information of their IgM or IgG SARS-CoV-2 antibodies. The test is intended for home  use or by a healthcare workers at point-of-care (e.g. nursing care or other healthcare facilities)